Literature DB >> 11386015

Benefits of the implementation of structured educational program in hypertension management.

A O Konrady1, I S Brodskaya, A V Soboleva, Y V Polunicheva.   

Abstract

BACKGROUND: The aim of the study was to evaluate the effect of patients' education on treatment compliance and blood pressure (BP) control, as well as lifestyle in hypertension.
MATERIAL AND METHODS: Education with the structured program was performed in 89 patients with essential hypertension. The patients knowledge level was determined using a special questionnaire with 26 questions. The regularity of BP self-control and drug treatment were assessed before and after the educational course as well as after 6-months of follow-up.
RESULTS: The knowledge level increased after education from 58 +/- 12% up to 92 +/- 11% (p < 0.05), the proportion of patients on regular medication from 34.4% to 74.2% (p < 0.05). Sixty (67.4%) of patients started to perform regular BP self-control. The improvement of knowledge level and treatment compliance was not accompanied by significant changes in lifestyle such as smoking cessation and body weight loss.
CONCLUSIONS: The structured patients' education resulted in the increase of patients' knowledge, improvement of drug compliance and self-monitoring of BP. Modification of lifestyle appears to be more problematic point as it did not show any significant improvement.

Entities:  

Mesh:

Year:  2001        PMID: 11386015

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  2 in total

1.  Evaluation of a hypertension-based patient education program in a stroke center.

Authors:  Nesrine Ben Nasr; Anne Rouault; Nicolas Cornillet; Marie Bruandet; Hélène Beaussier; Isabelle Tersen; Yvonnick Bezie; Mathieu Zuber
Journal:  Int J Clin Pharm       Date:  2018-11-26

2.  Impact of patient knowledge on hypertension treatment adherence and efficacy: A single-centre study in Poland.

Authors:  Anna Paczkowska; Karolina Hoffmann; Krzysztof Kus; Dorota Kopciuch; Tomasz Zaprutko; Piotr Ratajczak; Michał Michalak; Elżbieta Nowakowska; Wiesław Bryl
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.